Ivonescimab
UMCC 2025.012
Phase 2 mab active
Quick answer
Ivonescimab for Advanced Head and Neck Squamous Cell Carcinoma is a Phase 2 program (mab) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Advanced Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active